Fast Market Research

Just Released: "Emergent BioSolutions Inc. - Product Pipeline Review - 2013"

Fast Market Research recommends "Emergent BioSolutions Inc. - Product Pipeline Review - 2013" from Global Markets Direct, now available


Boston, MA -- (SBWIRE) -- 02/04/2014 -- Global Market Direct's pharmaceuticals report, "Emergent BioSolutions Inc. - Product Pipeline Review - 2013" provides data on the Emergent BioSolutions Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Emergent BioSolutions Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Emergent BioSolutions Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


- Emergent BioSolutions Inc. - Brief Emergent BioSolutions Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Emergent BioSolutions Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Emergent BioSolutions Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Emergent BioSolutions Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Emergent BioSolutions Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Emergent BioSolutions Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Emergent BioSolutions Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Emergent BioSolutions Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Emergent BioSolutions Inc. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Anthrax - Pipeline Review, H1 2013
- Emergent BioSolutions Inc. (EBS) - Financial and Strategic SWOT Analysis Review
- Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2013
- T-Cell Lymphomas - Pipeline Review, H1 2013
- Clostridium Infections - Pipeline Review, H1 2013
- Pandemic Influenza - Pipeline Review, H2 2013
- Polycystic Kidney Disease - Pipeline Review, H2 2013
- Typhoid Fever - Pipeline Review, H1 2013
- B-Cell Leukemia - Pipeline Review, H2 2013
- Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013